9. From “morphology” to “metabolic”
• ベースライン時のPETにおける集積度合いを
治療後と比較することで行われる
• 1999年,European Organization for Research
and Treatment of Cancer (EORTC) によりPETを
用いた治療効果判定が初めて提案
• RECIST 1.1では,「新規病変」に関してのみ
PETによる治療効果判定が部分的に導入
13. PERCISTとは
• PET Response Criteria in Solid Tumors
Richard L. Wahl, et al. : From RECIST to PERCIST: Evolving
Considerations for PET Response Criteria in Solid Tumors,
J Nucl Med. 2009;50(1):122S–150S.
23. 体重とSUVの相関
Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL.
Reevaluation of the standardized uptake value for FDG:
variations with body weight and methods for correction.
Radiology 1999;213:521–525.
体重により補正 除脂肪体重により補正
SUV
SUL
27. 関心領域の値
Richard L. Wahl, et al.
From RECIST to PERCIST:
Evolving Considerations for PET Response Criteria in Solid Tumors,
J Nucl Med. 2009;50(1):122S–150S.
29. 最大値とピーク値の比較
Martin A. Lodge, Muhammad A. Chaudhry, and Richard L. Wahl
Noise Considerations for PET Quantification
Using Maximum and Peak Standardized Uptake Value
J Nucl Med. 2012;53(7):1041-7.
最大値 ピーク値
32. 閾値
Richard L. Wahl, et al.
From RECIST to PERCIST:
Evolving Considerations for PET Response Criteria in Solid Tumors,
J Nucl Med. 2009;50(1):122S–150S.
39. 参考文献
• Wahl RL, Jacene H, Kasamon Y, Lodge MA.
From RECIST to PERCIST Evolving Considerations for
PET Response Criteria in Solid Tumors
J Nucl Med. 2009;50(1):122S–150S.
• SIEMENS
Expanding the Power of PET with PERCIST
• M. Yanagawa et al.
Evaluation of Response to Neoadjuvant Chemotherapy
for Esophageal Cancer: PET Response Criteria in Solid
Tumors Versus Response Evaluation Criteria in Solid
Tumors
J Nucl Med. 2012;53(6):872-80.